← Back
Data updated: Jul 17, 2026
CHEMISCH FBRK KRSSLR
Pharma Pharmaceuticals
CHEMISCH FBRK KRSSLR is a pharmaceutical company with 1 FDA-approved products.
2010
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Small Molecules
CHEMISCH FBRK KRSSLR's Key Drugs
CHEMISCH FBRK KRSSLR's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
CHEMISCH FBRK KRSSLR's Recent FDA Approvals
New NDA/BLA approvals for CHEMISCH FBRK KRSSLR over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
CHEMISCH FBRK KRSSLR's Therapeutic Areas
Disease areas where CHEMISCH FBRK KRSSLR has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
CHEMISCH FBRK KRSSLR Pipeline Snapshot
Active clinical trials for CHEMISCH FBRK KRSSLR across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2010-03-30
- Latest
- 2025-01-30
- Applications
- 1